Follow Us x
Proven efficacy in both laboratory studies and real-world settings
ActivePure® is the technology proven to reduce pathogens in the air and on surfaces in real-time.
Devices with ActivePure Technology have been proven against a wide-range of pathogens
- SARS-CoV-2 (virus)
- Staphylococcus Aureus (Gram+ bacteria)
- Aspergillus Niger (endospore; Toxic Black Mold surrogate)
- H1N1 (Swine Flu; Influenza A virus)
- H5N8 (Bird Flu; Influenza A virus)
- Methicillin-Resistant Staphylococcus Aureus (MRSA; Gram+ bacteria)
- Bacillus Globigii (bacterial endospore; Anthrax surrogate)
- MS2 (RNA bacteriophage virus)
- Staphylococcus Epidermis (Gram+ bacteria)
- Phi-X174 (DNA bacteriophage virus)
- Erwinia Herbicola (Gram- bacteria)
- Listeria Monocytogenes (Gram+ bacteria)
- Murine Norovirus (virus)
- Escherichia Coli (E. Coli; Gram- bacteria)
- Candida Auris (fungus)
- Botrytis Cinerea (fungus)
- Sclerotinia Sclerotiorum (fungus)
- Legionella Pneumophila (Gram- bacteria)
- Aspergillus Versicolor (fungus)
- Clostridioides Difficile (C. Diff; endospore)
- Salmonella Enterica (Gram- bacteria)
- MPX-HUG-2 (Monkeypox; virus)
ActivePure®
ActivePure® Technology is scientifically proven to be ≥ 99.9% effective against:
To learn more about the hierarchy of pathogens, review Dr. William Rutala's Overview of Current Disinfection Hierarchy Models.
Spores
Bacillus Globigii (Spore)
(Same category as Clostridioides Difficile)
Mycobacteria
Testing completed against harder pathogens
(Category of Mycobacterium Tuberculosis)
Non-Enveloped Viruses
MS2 & Phi-X 174 (Non-Enveloped Viruses)
(Same category as Norovirus, Polio & HAV [Hepatitis A Virus])
Fungi
Aspergillus Niger (Fungi)
(Same category as Candida Auris & Trichophyten)
Bacteria
Staphylococcus Epidermis & Erwinia Herbicola (Bacteria)
(Same category as MRSA, VRE & Acinetobacter)
Enveloped Viruses
Testing completed against harder pathogens
(Category of H1N1 [Swine Flu] H5N8 [Bird Flu] & SARS-CoV-2)
Peer-reviewed science
ActivePure is committed to the highest scientific standards, with multiple peer-reviewed studies in progress. Our first study on health care associated infection (HAI) reduction has recently been published in the American Journal of Infection Control. This study is on the pioneering edge of demonstrating that continuous decontamination can reduce surface, floor, and air contamination and thereby reduce the acquisition of HAIs.
